Hetero

Hetero Hetero is one of India’s leading generic pharmaceutical companies and the world’s largest produc

Hetero is one of India’s leading generic pharmaceutical companies and world’s largest producer of anti-retroviral drugs for the treatment of HIV/AIDS. Having 20+ years of expertise in the pharmaceutical industry, Hetero’s strategic business areas include APIs, Formulations, Biosimilars and Custom Pharmaceutical Services (CPS). The company is recognized for its strengths in Research and Development, Manufacturing and Commercialization of a wide range of products around the world. Hetero has 25+ state-of-the-art manufacturing facilities strategically located worldwide. And a majority of these facilities have been approved by stringent regulatory authorities like US FDA, EU, TGA-Australia, MCC - South Africa among others. We are endowed with a robust portfolio of above 200 products encompassing major therapeutic categories such as HIV/AIDS, Oncology, Cardiovascular, Neurology, Hepatitis, etc. Hetero has a strong global presence in 120+ countries and focusses on making affordable medicines accessible to patients worldwide.

03/12/2025

Glimpses from our last week , CPHI India!
We’re carrying forward the energy and momentum from meaningful collaborations and insightful conversations with the pharmaceutical community - fueling our shared mission to advance patient outcomes through life-saving and affordable therapeutics worldwide.

01/12/2025

We’ve come a long way in responding to the AIDS crisis — to a point where prevention truly can be better than cure. Preventive medicines like pre-exposure prophylaxis (PrEP) can reduce the risk of acquiring HIV by up to 99% when taken consistently. This is one of the most important breakthroughs in public health.



But progress only matters if it reaches everyone, everywhere. That demands a collective will to ensure affordable, life-saving treatment and prevention for all.



This World AIDS Day, we at Hetero reaffirm our commitment to making an AIDS-free world possible.

H

We’re delighted to be at ICASA 2025 – Africa’s largest convening dedicated to reducing the impact of HIV/AIDS, Tuberculo...
01/12/2025

We’re delighted to be at ICASA 2025 – Africa’s largest convening dedicated to reducing the impact of HIV/AIDS, Tuberculosis, Hepatitis and Malaria, and championing social justice and equitable access to treatment.

At Hetero, advancing patient outcomes through the manufacturing and supply of life-saving, affordable antiretroviral (ARV) APIs and finished formulations is at the heart of what we do every day.

Visit us to explore how we can work together to help end AIDS as a global health threat by 2030.

Booth 3 | 3–8 December 2025 | Accra International Conference Centre, Ghana


What an inspiring 3 days for us hashtag , CPHI & PMEC India! The meaningful collaborations and insightful conversations ...
27/11/2025

What an inspiring 3 days for us hashtag , CPHI & PMEC India!

The meaningful collaborations and insightful conversations with the pharmaceutical community are driving us forward in our shared mission: advancing patient outcomes through life-saving and affordable therapeutics worldwide.

22/11/2025

Antimicrobial Resistance (AMR) is not a distant threat - it’s already here.

Drug-resistant infections are rising and putting our health, food systems, environment and economies at risk, yet awareness, investment and action still lag behind.

Nearly 5 million deaths worldwide are associated with bacterial AMR, with 1.3 million directly attributable to it.
1 in 6 bacterial infections globally is caused by bacteria resistant to antibiotics.
Source: WHO Global Antibiotic Resistance Surveillance Report 2025

AMR is changing how safely we can perform surgeries, treat cancer, manage infections and protect our families.

From 18–24 November, World AMR Awareness Week (WAAW) calls on all of us to use antimicrobials responsibly and safeguard their effectiveness for the future.



At Hetero, we are committed to advancing a healthier world by advocating for wise prescription and responsible use of antibiotics, and by supporting solutions that help combat antimicrobial resistance.



Hetero is gearing up for CPHI & PMEC India 2025!Come say hello and explore our latest advancements in APIs, formulations...
21/11/2025

Hetero is gearing up for CPHI & PMEC India 2025!

Come say hello and explore our latest advancements in APIs, formulations and sustainable manufacturing that are shaping access to quality medicines worldwide.

Let’s connect and collaborate to enable a healthier future.

Booth No 2.A02 | India Expo Centre, Greater Noida | 25 - 27 November 2025

14/11/2025

affects people across every stage of life. When left undiagnosed or unmanaged, it can lead to serious complications affecting the heart, kidneys, eyes, and nerves.

This World Diabetes Day, let’s emphasise the importance of early detection and routine monitoring - small steps that enable better management, healthier outcomes, and a stronger quality of life.

According to ICMR, over 1.4 million new cancer cases are reported in India every year - a number projected to rise in th...
07/11/2025

According to ICMR, over 1.4 million new cancer cases are reported in India every year - a number projected to rise in the coming decade. Most diagnoses still occur at later stages, making treatment more challenging and outcomes less favorable.

Early detection saves lives. When identified early, many cancers can be treated more effectively, offering patients better recovery and quality of life.

01/11/2025

Here are a few glimpses from

The collaborations and conversations we had with the global pharmaceutical community are taking us closer to our shared goal of improving patient outcomes through life-saving therapeutics across geographies.

live from CPHI Worldwide 2025!Step in to connect, collaborate, and share ideas that inspire human belief in a healthie...
29/10/2025

live from CPHI Worldwide 2025!

Step in to connect, collaborate, and share ideas that inspire human belief in a healthier world.

We’re excited to meet you at our Booth 9.1 B6 !

Head to Booth 9.1 B6 at .Meet the Hetero team and explore opportunities to collaborate across APIs, FDFs, Biosimilars a...
28/10/2025

Head to Booth 9.1 B6 at .
Meet the Hetero team and explore opportunities to collaborate across APIs, FDFs, Biosimilars and CDMO.

Let’s inspire human belief in a healthier world, together!

Sustainability is our pathway to a healthier world.Hetero’s global ESG commitment drives meaningful impact – empowering ...
27/10/2025

Sustainability is our pathway to a healthier world.
Hetero’s global ESG commitment drives meaningful impact – empowering communities and ensuring a healthier tomorrow for all.

Join us at CPHI Frankfurt 2025 | Booth 9.1 B6

Charting the course to a sustainable future

Address

7-2-A2, Hetero Corporate Industrial Estates, Sanath Nagar
Hyderabad
500018

Opening Hours

Monday 9am - 6pm
Tuesday 9am - 6pm
Wednesday 9am - 6pm
Thursday 9am - 6pm
Friday 9am - 6pm
Saturday 9am - 6pm

Telephone

+914023704923

Website

Alerts

Be the first to know and let us send you an email when Hetero posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Hetero:

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Our Story

Hetero is one of India’s leading generic pharmaceutical companies and the world’s largest producer of anti-retroviral drugs. Backed by 25 years of expertise in the pharmaceutical industry, Hetero’s strategic business areas spread across APIs, generics, biosimilars, custom pharmaceutical services and branded generics. The company is globally recognized for its strengths in Research and Development, manufacturing and commercialization of a wide range of products.

Hetero has 36 state-of-the-art manufacturing facilities strategically located worldwide, approved by stringent global regulatory authorities. Our portfolio includes 300 plus products encompassing major therapeutic categories such as HIV/AIDS, Oncology, Cardiovascular, Neurology, Hepatitis, Nephrology, Urology, Diabetes, Ophthalmology, Hepatology and Immunology etc.

Hetero has a strong global presence in over 126 countries and focusses on making affordable medicines accessible to patients worldwide.